Related Experiment Video
Updated: Mar 1, 2026

Fluorescence Anisotropy as a Tool to Study Protein-protein Interactions
Published on: October 21, 2016
Isomer-specific binding affinity of perfluoroalkyl substances with red blood cells
Jianli Qu1, Tian Xia1, Haomiao Yu1
1College of Environmental Science and Engineering, Zhejiang University of Water Resources and Electric Power, Hangzhou, Zhejiang 310018, PR China.
Abstract:
Wide presence of perfluoroalkyl substances (PFASs) in human blood has attracted great attention. Interactions of PFASs with serum proteins have been well investigated, but with red blood cells (RBCs), a nonnegligible cellular constituent of blood, remains not well known. In this study, rat and human RBCs were incubated with PFASs (10 or 100 ng/mL) to investigate their isomer-specific binding affinity (Fr; mass fraction in RBCs). Immobilized artificial membrane (IAM) chromatography was used to assess the isomer-specific sorption of PFASs to RBC membranes (KIAM; retention capacity factor). Fr calculation suggested that binding affinity of linear perfluoroalkyl carboxylates (PFCAs) with rat and human RBCs consistently increased with chain length. Perfluorohexane sulfonate (PFHxS) exhibited lower mean Fr than perfluorooctane sulfonate (PFOS) and perfluorobutane sulfonate (PFBS), suggesting weak RBC affinity. Log KIAM of PFCAs linearly increased as perfluoroalkyl chain length increased from C4- (mean 0.61) to C14-PFCAs (0.68), and a similar trend was observed between PFBS (2.1) and PFOS (4.8). Branched perfluorooctanoate, PFOS, and perfluorooctane sulfonamide (PFOSA) isomers showed weaker binding than linear isomers. PFOSA showed higher affinity with rat and human RBCs and IAM, than PFOS. Overall, this study provides important data for understanding the behaviors and fate of PFASs in human blood.
More Related Videos
11:11Determination of Plasma Membrane Partitioning for Peripherally-associated Proteins
Published on: June 15, 2018
09:04Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow
Published on: April 18, 2019
Related Concept Videos
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
Drug Distribution: Plasma Protein Binding
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Affinity Chromatography